back pain semaglutide Doctors warn rapid weight loss from popular medications can cause Do GLP-1 medications help back

doi: 10.2337/dc18-1446 22 LavensADe BlockCOriotPCrenierLPhilipsJCVandenbrouckeMet al

Ozempic, Rybelsus, Wegovy, Mounjaro, Trulicity and Zepbound remain approved by the U.S

The combination therapy resulted in 13.7% weight loss and 1.8% HbA1c decrease compared to 3.4% and 0.4% in the placebo group

the other is a duet

Short non-diabetic data support remaining at 2.5 mg when weight and insulin-resistance markers are already moving and tolerability favors a hold. The label still positions 2.5 mg as the starter before 5 mg, so it is a defensible low-dose floor for selected users rather than a replacement for the 5 mg obesity-trial floor

These 2 nutrients are the heart of the process and interdependent So if one is imbalanced, it may cause an excess of the other